Alliance Pharma announces its results for 2014
25 March 2015 | By Victoria White
Alliance Pharma plc, the speciality pharmaceutical company, has announced its results for 2014. Figures show a modest dip in sales and profit...
List view / Grid view
News
Merger between Daiichi Sankyo subsidiary Ranbaxy and Sun Pharma completed
25 March 2015 | By Victoria White
Daiichi Sankyo have announced that the Sun Pharma and Ranbaxy merger process has been completed...
Commission on urgent care for older people launched by NHS Confederation
25 March 2015 | By Victoria White
A Commission to drive improvements in urgent and emergency care for older people in and outside of hospitals is being launched by the NHS Confederation...
Ocata Therapeutics licenses induced pluripotent stem cell (iPSC) technology from Allele Biotechnology
24 March 2015 | By Victoria White
Ocata has announced that it has entered into a definitive agreement with Allele to access Allele’s proprietary technology for generating human iPSCs...
NDA Group leads on integrated regulatory and HTA strategy at DIA Euromeeting 2015
24 March 2015 | By Victoria White
NDA Group will discuss the benefits of integrating regulatory and HTA strategy at the upcoming 27th Annual DIA EuroMeeting, 13-15th April in Paris...
Saxenda approved in Europe for the treatment of obesity
24 March 2015 | By Victoria White
Novo Nordisk has announced that the European Commission has granted marketing authorisation for Saxenda ® (liraglutide 3 mg) for the treatment of obesity...
Cobalt Light Systems launches new US company
24 March 2015 | By Cobalt Light Systems
Cobalt Light Systems, Ltd announces the formation of a US subsidiary company to support increasing demand for its novel pharmaceutical products...
Thomson Reuters names most promising drugs of 2015
24 March 2015 | By Victoria White
The Intellectual Property and Science business of Thomson Reuters has released the 2015 edition of its annual Drugs to Watch report...
Aerie Pharmaceuticals completes enrollment in second Phase 3 registration trial of Rhopressa
24 March 2015 | By Victoria White
Aerie Pharmaceuticals has announced the completion of enrollment in the Company’s second Phase 3 registration trial (“Rocket 2”) of Rhopressa...
EU Disease Lens brings visibility and insight into the most critical diseases
24 March 2015 | By Victoria White
Janssen Health Policy Centre (Janssen Pharmaceutica NV) today unveiled the EU Disease Lens: a digital dashboard that brings insight into 15 major diseases...
Biogen Idec presents positive interim results from Phase 1b study of investigational Alzheimer’s Disease treatment aducanumab
23 March 2015 | By Victoria White
Biogen Idec has announced data from the Phase 1b study of aducanumab, in which the drug demonstrated positive results in patients with prodromal or mild AD...
PANalytical launched new compact benchtop XRF system for pharmaceutical catalysts analysis
23 March 2015 | By PANalytical
PANalytical launched a new Epsilon 1 XRF analyzer at last year’s meeting of the American Association of Pharmaceutical Sciences (AAPS) in California...
Vaccination for measles must be scaled up in Ebola-affected countries, says the World Health Organization
23 March 2015 | By Victoria White
A growing risk of outbreaks of vaccine-preventable diseases in countries affected by Ebola must be countered by the scaling up of routine immunisation...
Heparin helps in understanding a natural HIV barrier
23 March 2015 | By Victoria White
Heparin, a blood thinning agent, is helping researchers at the University of East Anglia (UEA) understand more about the body’s natural barriers to HIV...
First-in-class type 2 diabetes treatment GLYXAMBI tablets for adults now available in U.S. pharmacies
23 March 2015 | By Victoria White
GLYXAMBI® tablets are now available by prescription in the US. GLYXAMBI offers improved glycemic control as an adjunct to diet and exercise...
